Progyny Inc reports results for the quarter ended December 31 - Earnings Summary

• Progyny Inc PGNY.OQ reported quarterly adjusted earnings of 12 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 13 cents. The mean expectation of ten analysts for the quarter was for earnings of 10 cents per share. Wall Street expected results to range from 8 cents to 15 cents per share.

• Revenue rose 10.6% to $298.43 million from a year ago; analysts expected $276.68 million.

• Progyny Inc's reported EPS for the quarter was 12 cents​.

• The company reported quarterly net income of $10.53 million.

• Progyny Inc shares had risen by 33.3% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 3.1% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 7 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the managed healthcare peer group is "hold."

Wall Street's median 12-month price target for Progyny Inc is $23.00

This summary was machine generated from LSEG data February 27 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)